<code id='CA2E459420'></code><style id='CA2E459420'></style>
    • <acronym id='CA2E459420'></acronym>
      <center id='CA2E459420'><center id='CA2E459420'><tfoot id='CA2E459420'></tfoot></center><abbr id='CA2E459420'><dir id='CA2E459420'><tfoot id='CA2E459420'></tfoot><noframes id='CA2E459420'>

    • <optgroup id='CA2E459420'><strike id='CA2E459420'><sup id='CA2E459420'></sup></strike><code id='CA2E459420'></code></optgroup>
        1. <b id='CA2E459420'><label id='CA2E459420'><select id='CA2E459420'><dt id='CA2E459420'><span id='CA2E459420'></span></dt></select></label></b><u id='CA2E459420'></u>
          <i id='CA2E459420'><strike id='CA2E459420'><tt id='CA2E459420'><pre id='CA2E459420'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:66539
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Commercial surrogacy can be ethical, despite pope’s claims
          Commercial surrogacy can be ethical, despite pope’s claims

          AdobeOverthepastfewyears,IhavewatchedawonderfulyoungboyI’llcallChadgrowupsmartandfulloflife.Hisparen

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          Novo Nordisk to expand supply of Wegovy for U.S. patients

          BloombergphotobyGeorgeFreyLONDON—NovoNordisksaidWednesdaythatithadstartedtoincreasetheavailabilityof